Gastrointestinal and hepatic manifestations of COVID-19: A systematic review and meta-analysis.
Robert D DorrellMichael K DoughertyEric L BarashAsher E LichtigSteven B ClaytonElizabeth T JensenPublished in: JGH open : an open access journal of gastroenterology and hepatology (2020)
Patients with isolated GI symptoms may represent a small but significant portion of COVID-19 cases. When testing resources are abundant, clinicians should still consider testing patients with isolated GI symptoms or unexplained transaminase elevations for COVID-19. More recent studies estimate higher overall GI involvement in COVID-19 than was previously recognized.